December 8, 2023 10:52 AM EST
News Briefing

No­var­tis preps Kisqali for FDA; Ven­tyx cuts 20% of work­ers; Keytru­da plus Lenvi­ma hits PhI­II set­back

Ayisha Sharma

News Reporter

Plus news about Rigel Phar­ma­ceu­ti­cals col­lab­o­rat­ing with MD An­der­son.

No­var­tis up­dates PhI­II da­ta for Kisqali: The com­pa­ny has al­ready filed

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times